Call Options Transactions Made in Q2 2024 in Ascendis Pharma A/S (ASND)
This table provides information about the institutional ownership of Ascendis Pharma A/S (ASND) during Q2 2024. The information is specifically focused on institutions that hold call options of Ascendis Pharma A/S.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
17.2K+ 111.69% |
$2.08M - $2.64M
|
32.6K
$4.21M
|
|
|
Aug 15, 2024
Q2 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
12.4K+ 18.48% |
$1.5M - $1.91M
|
79.5K
$10.3M
|
|
|
Aug 13, 2024
Q2 2024
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
CALL |
9.1KNew |
$1.1M - $1.4M
|
9.1K
$1.18M
|
|
|
Aug 14, 2024
Q2 2024
|
Lmr Partners LLP
London, X0 |
BUY
|
CALL |
4KNew |
$484K - $615K
|
4K
$517K
|
|
|
Aug 14, 2024
Q2 2024
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
CALL |
-1K- 33.33% |
$121K - $154K
|
2K
$258K
|
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
CALL |
-12.3K- 49.6% |
$1.49M - $1.89M
|
12.5K
$1.61M
|